(4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione

C47H71N7O8 — CID 130456163

IUPAC(4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione
SMILESCC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)C(N(C)C)C2O)[C@@H](CCN(C)Cc2cn(-c3cnc4ccccc4c3)nn2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CCN(C)C
InChIInChI=1S/C47H71N7O8/c1-11-41-34(18-20-51(6)7)22-29(2)16-17-39(55)30(3)23-35(19-21-53(10)27-36-28-54(50-49-36)37-24-33-14-12-13-15-38(33)48-26-37)46(31(4)40(56)25-42(57)61-41)62-47-45(59)43(52(8)9)44(58)32(5)60-47/h12-17,22,24,26,28,30-32,34-35,40-41,43-47,56,58-59H,11,18-21,23,25,27H2,1-10H3/b17-16+,29-22+/t30-,31+,32-,34+,35+,40-,41-,43?,44-,45?,46-,47+/m1/s1
InChIKeyAFMKXRCNVAJMEA-OIDIIPARSA-N
MW862.13 g/mol
LogP4.42
Rot. Bonds13

About (4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione

(4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione (PubChem CID 130456163) has the molecular formula C47H71N7O8 and a molecular weight of 862.13 g/mol. Its IUPAC name is (4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione.

Molecular Properties

Compound Name(4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione
PubChem CID130456163
Molecular FormulaC47H71N7O8
Molecular Weight862.13 g/mol
Exact Mass861.54
IUPAC Name(4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione
SMILESCC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)C(N(C)C)C2O)[C@@H](CCN(C)Cc2cn(-c3cnc4ccccc4c3)nn2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CCN(C)C
InChIInChI=1S/C47H71N7O8/c1-11-41-34(18-20-51(6)7)22-29(2)16-17-39(55)30(3)23-35(19-21-53(10)27-36-28-54(50-49-36)37-24-33-14-12-13-15-38(33)48-26-37)46(31(4)40(56)25-42(57)61-41)62-47-45(59)43(52(8)9)44(58)32(5)60-47/h12-17,22,24,26,28,30-32,34-35,40-41,43-47,56,58-59H,11,18-21,23,25,27H2,1-10H3/b17-16+,29-22+/t30-,31+,32-,34+,35+,40-,41-,43?,44-,45?,46-,47+/m1/s1
InChIKeyAFMKXRCNVAJMEA-OIDIIPARSA-N
XLogP4.42
TPSA175.84 Ų
H-Bond Donors3
H-Bond Acceptors15
Rotatable Bonds13
Heavy Atoms62
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500862.13
LogP ≤ 54.42
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1015

Analyze (4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione?
The IUPAC name of (4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione (CID 130456163) is (4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione.
What is the SMILES notation for (4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione?
The canonical SMILES for (4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione is CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)C(N(C)C)C2O)[C@@H](CCN(C)Cc2cn(-c3cnc4ccccc4c3)nn2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CCN(C)C.
What is the InChIKey of (4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione?
The InChIKey is AFMKXRCNVAJMEA-OIDIIPARSA-N. The full InChI is InChI=1S/C47H71N7O8/c1-11-41-34(18-20-51(6)7)22-29(2)16-17-39(55)30(3)23-35(19-21-53(10)27-36-28-54(50-49-36)37-24-33-14-12-13-15-38(33)48-26-37)46(31(4)40(56)25-42(57)61-41)62-47-45(59)43(52(8)9)44(58)32(5)60-47/h12-17,22,24,26,28,30-32,34-35,40-41,43-47,56,58-59H,11,18-21,23,25,27H2,1-10H3/b17-16+,29-22+/t30-,31+,32-,34+,35+,40-,41-,43?,44-,45?,46-,47+/m1/s1.
What are the key properties of (4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione?
(4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione has a molecular weight of 862.13 g/mol, XLogP of 4.42, 13 rotatable bonds, 3 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for (4R,5S,6S,7R,9R,11E,13E,15S,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-15-[2-(dimethylamino)ethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-[2-[methyl-[(1-quinolin-3-yltriazol-4-yl)methyl]amino]ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione is sourced from PubChem (CID 130456163), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).